Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rumeric Bolus is a veterinary nutritional and metabolic supplement developed and distributed by Sam Pharmaceutical (Sams Pharmaceutical) and manufactured by Impact Labs. Formulated as an oral bolus for livestock, including cattle, sheep, and goats, it contains a synergistic blend of essential minerals and vitamins: dried ferrous sulfate, cobalt chloride, copper sulfate, thiamine (vitamin B1), and cyanocobalamin (vitamin B12). Rumeric Bolus is indicated for the treatment of anorexia, hyperactive ruminal indigestion, and simple indigestion in animals. It works by reviving normal and viable ruminal microflora populations, restoring rumeno-reticular motility, and optimizing rumen and liver function, which ultimately improves appetite, digestion, milk production, and milk fat in livestock.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rumeric Bolus.